AR025646A1 - Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa. - Google Patents

Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa.

Info

Publication number
AR025646A1
AR025646A1 ARP000104797A ARP000104797A AR025646A1 AR 025646 A1 AR025646 A1 AR 025646A1 AR P000104797 A ARP000104797 A AR P000104797A AR P000104797 A ARP000104797 A AR P000104797A AR 025646 A1 AR025646 A1 AR 025646A1
Authority
AR
Argentina
Prior art keywords
yeast strain
insulin precursor
strain
cepa
producers
Prior art date
Application number
ARP000104797A
Other languages
English (en)
Original Assignee
Beta Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beta Lab Sa filed Critical Beta Lab Sa
Priority to ARP000104797A priority Critical patent/AR025646A1/es
Priority to MXPA01008690A priority patent/MXPA01008690A/es
Priority to BR0105162-8A priority patent/BR0105162A/pt
Priority to CA2357072A priority patent/CA2357072C/en
Priority to US09/955,259 priority patent/US7091032B2/en
Priority to EP01121987A priority patent/EP1211314A3/en
Publication of AR025646A1 publication Critical patent/AR025646A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de ADN y método para obtener la cepa. Dicha cepacomprende en su genoma por lo menos una copia de una primera construccion de ADN y una segundacons truccion de ADN, donde dichas construcciones de ADN soncapaces de dirigir la expresion y liberacion al medio de un precursor de insulina humana de la formula: B(1-30)-Y1-Y2-A(1-21), donde Y1 es lisina o arginina;Y2 es lisina o arginina; B(1-30)es el péptido B de la insulina humana; y A(1-21) es el péptido A de la insulina humana y donde la cepa de levadurascorresponde a una cepa de levadura de Pichia Pastoris.
ARP000104797A 2000-09-13 2000-09-13 Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa. AR025646A1 (es)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ARP000104797A AR025646A1 (es) 2000-09-13 2000-09-13 Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa.
MXPA01008690A MXPA01008690A (es) 2000-09-13 2001-08-27 Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa.
BR0105162-8A BR0105162A (pt) 2000-09-13 2001-09-12 Cepa de leveduras metilotróficas recombinantes produtoras de um precursor de insulina, construções do dna e método para a obtenção da cepa
CA2357072A CA2357072C (en) 2000-09-13 2001-09-12 Expression of a human insulin precursor in p. pastoris
US09/955,259 US7091032B2 (en) 2000-09-13 2001-09-12 Expression of a human insulin precursor in P. pastoris
EP01121987A EP1211314A3 (en) 2000-09-13 2001-09-13 Expression of a human insulin precursor in p. pastoris

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP000104797A AR025646A1 (es) 2000-09-13 2000-09-13 Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa.

Publications (1)

Publication Number Publication Date
AR025646A1 true AR025646A1 (es) 2002-12-04

Family

ID=3460837

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000104797A AR025646A1 (es) 2000-09-13 2000-09-13 Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa.

Country Status (6)

Country Link
US (1) US7091032B2 (es)
EP (1) EP1211314A3 (es)
AR (1) AR025646A1 (es)
BR (1) BR0105162A (es)
CA (1) CA2357072C (es)
MX (1) MXPA01008690A (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003278550A1 (en) * 2002-12-05 2004-06-23 Edupuganti B. Raju Process for the extraction and isolation of insulin from recombinant sources
CN100460508C (zh) * 2004-11-03 2009-02-11 马延高 人胰岛素基因在甲醇酵母中的分泌表达方法
DE102006031955A1 (de) * 2006-07-11 2008-01-17 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung von Insulinanaloga mit dibasischem B-Kettenende
WO2008139496A1 (en) * 2007-05-16 2008-11-20 Bigtec Private Limited Recombinant human insulin and a method thereof
JP5547083B2 (ja) 2007-11-20 2014-07-09 アンブルックス,インコーポレイテッド 修飾されたインスリンポリペプチドおよびそれらの使用
MY161892A (en) * 2008-02-19 2017-05-15 Biocon Ltd A method of obtaining a purified, biologically active heterologous protein
CN103003438B (zh) * 2010-02-10 2016-01-20 拜康有限公司 减少蛋白质糖基化的方法和过程及其蛋白质
CN105087724B (zh) * 2014-05-04 2019-12-03 重庆派金生物科技有限公司 酵母重组表达门冬胰岛素的制备方法
AU2019218315A1 (en) * 2018-02-09 2020-07-09 Jiangsu Hengrui Medicine Co., Ltd. Codon optimized precursor gene and signal peptide gene of human insulin analogue

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431740A (en) 1979-09-12 1984-02-14 The Regents Of The University Of California DNA Transfer vector and transformed microorganism containing human proinsulin and pre-proinsulin genes
IE50892B1 (en) 1980-02-11 1986-08-06 Novo Industri As Process for preparing insulin esters
NZ199391A (en) 1981-01-02 1985-12-13 Genentech Inc Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
DK58285D0 (da) 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
DK129385A (da) 1985-03-22 1986-09-23 Novo Industri As Peptider og fremstilling deraf
PH25772A (en) 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
JPH06500470A (ja) * 1990-09-04 1994-01-20 メルク エンド カンパニー インコーポレーテッド メチロトローフ酵母細胞におけるインスリン様成長因子の産生
US5460954A (en) 1992-04-01 1995-10-24 Cheil Foods & Chemicals, Inc. Production of human proinsulin using a novel vector system
DE4405179A1 (de) 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
US5955349A (en) * 1996-08-26 1999-09-21 Zymogenetics, Inc. Compositions and methods for producing heterologous polypeptides in Pichia methanolica
CN1125081C (zh) * 1999-09-08 2003-10-22 中国科学院上海生物化学研究所 重组天然和新型人胰岛素及其制备方法

Also Published As

Publication number Publication date
US7091032B2 (en) 2006-08-15
CA2357072A1 (en) 2002-03-13
EP1211314A2 (en) 2002-06-05
US20030104607A1 (en) 2003-06-05
CA2357072C (en) 2012-07-10
MXPA01008690A (es) 2004-08-12
BR0105162A (pt) 2002-05-21
EP1211314A3 (en) 2002-07-10

Similar Documents

Publication Publication Date Title
AR025646A1 (es) Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa.
US6887470B1 (en) Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
US6849714B1 (en) Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
AU2003228962A1 (en) Ferritin fusion proteins for use in vaccines and other applications
BR0317994A (pt) Cepas de levedura recombinante que produzem a fermentação de xilose
ATE380822T1 (de) Funf-helix protein
CY1112833T1 (el) Καινοφανης προσδετης της κυτοκινης ζcυτοr17
EE200200709A (et) Liitvalku sisaldava kompositsiooni ning seda liitvalku ja liitpolüpeptiidi kodeeriva nukleiinhappe kasutamine
EP1623994A2 (en) Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
JP2004533208A5 (es)
AU1478802A (en) Dipeptidyl peptidases
ATE342359T1 (de) Design von beta-faltblatt-proteinen mit spezifischen bindungseigenschaften
NO20025153L (no) Fremgangsmåter og sammensetninger for å påvirke formering av HIV-1, HIV-2 og SIV
WO2006090385A3 (en) Protease inhibitors and method of screening thereof
DK1349944T3 (da) Latensassocieret peptid af TGF-beta til at bibringe farmaceutisk aktive proteiner latens
DE50304608D1 (de) Sandwich-immunoassay zur bestimmung von proanp-teilpeptiden
CN117229414A (zh) 丙型肝炎病毒e1/e2异二聚体及其生产方法
MY162658A (en) Genes encoding major capsid protein l1 of human papilloma virus and use of the same
ATE408631T1 (de) Chimäres protein welches eine intramolekulare chaperon-ähnliche sequenz enthält und dessen anwendung zur insulinproduktion
DE4402756A1 (de) Spezifische Bindungssubstanzen für Antikörper und deren Verwendung für Immunoassays oder Vakzine
ATE199394T1 (de) Gag-env fusion-antigen aus hiv
AU2003245781A1 (en) Mhc class ii peptide epitope of 5t4 antigen
DE50110723D1 (de) Isolierte luziferasen sowie deren verwendung
DE602005010276D1 (de) Neues peptid und pharmazeutische zusammensetzung, die dieses peptid enthält
ATE491785T1 (de) Oxidoreduktase

Legal Events

Date Code Title Description
FG Grant, registration